TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9461726

Group type: EXPERIMENTAL
Intervention: Salmeterol (50 micrograms twice daily)
Number of subjects: 0
Study: 8003847

Group type: EXPERIMENTAL
Intervention: Oral contraceptive users (n = 939)
Number of subjects: 3222

Group type: COMPARATOR
Intervention: Non-users (n = 2283)
Number of subjects: 3222

Group type: EXPERIMENTAL
Intervention: Oral contraceptive users (n = 939) among women who had never used oestrogen replacement therapy (n = 1427)
Number of subjects: 3222

Group type: COMPARATOR
Intervention: Non-users (n = 2283) among women who had never used oestrogen replacement therapy (n = 1427)
Number of subjects: 3222

Group type: EXPERIMENTAL
Intervention: Oral contraceptive users (n = 939) among premenopausal women (n = 387)
Number of subjects: 3222

Group type: COMPARATOR
Intervention: Non-users (n = 2283) among premenopausal women (n = 387)
Number of subjects: 3222
Study: 3341390

Group type: EXPERIMENTAL
Intervention: Indapamide 1 mg per day
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Indapamide 2.5 mg per day
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Indapamide 5.0 mg per day
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 29799999

Group type: EXPERIMENTAL
Intervention: Automated Bone Scan Index (aBSI)
Number of subjects: 1245
Study: 27507634

Group type: EXPERIMENTAL
Intervention: Standard care supplemented by a pain consultation combined with a patient pain education program
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 72
Study: 26514499

Group type: EXPERIMENTAL
Intervention: NPC home nursing plan
Number of subjects: 180
Study: 24133104

Group type: EXPERIMENTAL
Intervention: PNF physiotherapy
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional physiotherapy
Number of subjects: 34
Study: 21138901

Group type: EXPERIMENTAL
Intervention: S‐(+)‐ketamine
Number of subjects: 128

Group type: COMPARATOR
Intervention: Sufentanil
Number of subjects: 128
Study: 18197915

Group type: EXPERIMENTAL
Intervention: Auto-CPAP
Number of subjects: 41

Group type: COMPARATOR
Intervention: Fixed-CPAP
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 41
Study: 17184605

Group type: EXPERIMENTAL
Intervention: Fermented milk containing Lactobacillus casei and Streptococcus thermophilus (0.5 l/day) for 6 weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: Standard cow's milk (0.5 l/day) for 12 weeks
Number of subjects: 35
Study: 15004973

Group type: EXPERIMENTAL
Intervention: Zi-Factor (250 mg azithromycin capsules)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Reference-drug
Number of subjects: 18
Study: 10974397

Group type: EXPERIMENTAL
Intervention: Pluronic F-68 with nifedipine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nifedipine with fixed ratio of 1.5 (inner to outer layer)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nifedipine with a 1:1 ratio of inner to outer layer
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cardilate (test product)
Number of subjects: 12
Study: 8979392

Group type: EXPERIMENTAL
Intervention: Transference condition (activation of significant-other representation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transference condition
Number of subjects: 0
Study: 1435883

Group type: EXPERIMENTAL
Intervention: Dichloroacetate
Number of subjects: 252

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 252
Study: 6377153

Group type: EXPERIMENTAL
Intervention: Single 2-g oral dose of metronidazole (Flagyl)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Seven-day regimen of metronidazole
Number of subjects: 42
Study: 31518339

Group type: EXPERIMENTAL
Intervention: Web-based intervention (Group 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fitbit Charge HR (Group 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fitbit Charge HR and office visits (Group 3)
Number of subjects: 0
Study: 28383398

Group type: EXPERIMENTAL
Intervention: Probiotic product containing Bifidobacterium infantis R0033, Bifidobacterium bifidum R0071, and Lactobacillus helveticus R0052
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Probiotic product
Number of subjects: 200
Study: 25769076

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 98

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 98
Study: 23405164

Group type: EXPERIMENTAL
Intervention: Brain Age (brain training game)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Tetris (puzzle game)
Number of subjects: 32
Study: 21269980

Group type: EXPERIMENTAL
Intervention: Bedtime injection of glargine and oral antidiabetic drugs (group A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Injection of Novolin 30 R twice a day (group B)
Number of subjects: 0
Study: 19091420

Group type: EXPERIMENTAL
Intervention: Cataract surgery
Number of subjects: 4577
Study: 18693603

Group type: EXPERIMENTAL
Intervention: True Positive ETT
Number of subjects: 148

Group type: COMPARATOR
Intervention: False Positive ETT
Number of subjects: 148
Study: 14707416

Group type: EXPERIMENTAL
Intervention: Carotid angioplasty and stenting (CAS)
Number of subjects: 39
Study: 11257348

Group type: EXPERIMENTAL
Intervention: DTPa-HBV-IPV/Hib combination vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Separate Hib conjugates
Number of subjects: 0
Study: 9493717

Group type: EXPERIMENTAL
Intervention: Nocturnal asthma (NA) group
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Non-nocturnal asthma (NNA) group
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 45
Study: 8116704

Group type: COMPARATOR
Intervention: Video colposcope viewing (study 1)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Music video viewing (study 2)
Number of subjects: 57
Study: 3415794

Group type: EXPERIMENTAL
Intervention: Dinamap automated oscillometric blood pressure monitor
Number of subjects: 42
Study: 31876907

Group type: EXPERIMENTAL
Intervention: 23-month ticagrelor monotherapy following 1-month dual antiplatelet therapy (DAPT) after PCI
Number of subjects: 15991

Group type: COMPARATOR
Intervention: 12-month DAPT followed by 12-month aspirin monotherapy
Number of subjects: 15991

Group type: EXPERIMENTAL
Intervention: Experimental arm (ticagrelor)
Number of subjects: 15991

Group type: COMPARATOR
Intervention: Reference arm (DAPT followed by aspirin)
Number of subjects: 15991

Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 15991
Study: 31539276

Group type: EXPERIMENTAL
Intervention: Five differentially expressed long noncoding RNAs (LINC00475, LINC01352, MIR503HG, KCNMB2‐AS1, LINC01143) used to establish a risk score model.
Number of subjects: 526

Group type: EXPERIMENTAL
Intervention: Risk score model based on five DELs.
Number of subjects: 526

Group type: EXPERIMENTAL
Intervention: Risk score model.
Number of subjects: 526

Group type: EXPERIMENTAL
Intervention: Risk score in nomogram model.
Number of subjects: 526

Group type: EXPERIMENTAL
Intervention: Mechanism analyses of lncRNAs.
Number of subjects: 526
Study: 28250181

Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26390102

Group type: EXPERIMENTAL
Intervention: Sensor-Augmented Pump (SAP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Multiple Daily Injections (MDI)
Number of subjects: 60
Study: 23735264

Group type: EXPERIMENTAL
Intervention: Advance letter
Number of subjects: 1000

Group type: COMPARATOR
Intervention: No advance letter
Number of subjects: 1000
Study: 21687920

Group type: EXPERIMENTAL
Intervention: Nurse-led multidisciplinary programme (NMP) of pulmonary rehabilitation
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 103
Study: 18611978

Group type: EXPERIMENTAL
Intervention: Transdermal E(2) supplementation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline infusion (Control)
Number of subjects: 20
Study: 16488678

Group type: EXPERIMENTAL
Intervention: Clopidogrel administration 4 hours postoperatively, daily for 4 weeks
Number of subjects: 364

Group type: COMPARATOR
Intervention: No clopidogrel administration
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Clopidogrel administration
Number of subjects: 364
Study: 12560924

Group type: EXPERIMENTAL
Intervention: LSTs
Number of subjects: 65

Group type: COMPARATOR
Intervention: Exophytic tumors
Number of subjects: 65
Study: 11023194

Group type: EXPERIMENTAL
Intervention: Intratumoral interferon-gamma (IFN-gamma) retroviral vector, 10(7) plaque-forming units/mL administered at 0.3, 0.5, and 1.0 mL per cohort of patients, five daily injections every 2 weeks.
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Intratumoral interferon-gamma (IFN-gamma) retroviral vector, multiple injections.
Number of subjects: 17
Study: 9376465

Group type: EXPERIMENTAL
Intervention: Metamizol (1 g/100 ml NaCl 0.9% intravenously over 15 min) plus diclofenac (100 mg suppository) administered before induction and repeated at 6 h and 12 h.
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo (not explicitly detailed in the abstract).
Number of subjects: 74
Study: 8368464

Group type: EXPERIMENTAL
Intervention: Cetirizine (10 mg once daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Terfenadine (60 mg twice daily)
Number of subjects: 30
Study: 3010626

Group type: EXPERIMENTAL
Intervention: Midazolam (Ro 21-3981) at 0.2 mg . kg‐1
Number of subjects: 90

Group type: COMPARATOR
Intervention: Diazepam at 0.3 mg . kg‐1
Number of subjects: 90
Study: 31592880

Group type: EXPERIMENTAL
Intervention: Hybrid training system with walking
Number of subjects: 28

Group type: COMPARATOR
Intervention: Transcutaneous electrical nerve stimulation
Number of subjects: 28
Study: 29580238

Group type: EXPERIMENTAL
Intervention: Community Health Workers (CHWs) treatment for SAM
Number of subjects: 934

Group type: COMPARATOR
Intervention: Traditional facility-based treatment for SAM
Number of subjects: 934
Study: 27751762

Group type: EXPERIMENTAL
Intervention: 50 mg of losartan (angiotensin-receptor blocker) for 3 days
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 25170262

Group type: EXPERIMENTAL
Intervention: Behavioral medicine in physical therapy intervention
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 23
Study: 22371040

Group type: EXPERIMENTAL
Intervention: Fabric-based biopsy
Number of subjects: 55

Group type: COMPARATOR
Intervention: Conventional biopsy (punch biopsy, sharp endocervical curettage)
Number of subjects: 55
Study: 19583779

Group type: EXPERIMENTAL
Intervention: Untreated epilepsy patients
Number of subjects: 155

Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 155
Study: 18375982

Group type: EXPERIMENTAL
Intervention: Atenolol (At) strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Verapamil-SR (Ve) strategy
Number of subjects: 0
Study: 16002806

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (500 mg Ca/d for 1 year)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 113
Study: 12468439

Group type: EXPERIMENTAL
Intervention: High-dose fluticasone propionate (500 microg twice a day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Low-dose fluticasone propionate (100 microg twice a day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control subjects (8 subjects)
Number of subjects: 30
Study: 10337856

Group type: EXPERIMENTAL
Intervention: Sitostanol ester-rich margarine (campestanol to sitostanol ratio 1:11)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Campestanol ester-rich margarine (campestanol to sitostanol ratio 1:2)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Sitostanol ester-rich butter (campestanol to sitostanol ratio 1:13)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control (butter period)
Number of subjects: 23
Study: 8750370

Group type: EXPERIMENTAL
Intervention: Intravenous TCA (2 mg as phosphate ester)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral TCA (5 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhaled TCA (2 mg)
Number of subjects: 0
Study: 2345211

Group type: EXPERIMENTAL
Intervention: Composite resin restoration
Number of subjects: 40

Group type: COMPARATOR
Intervention: Amalgam restoration
Number of subjects: 40
Study: 7408529

Group type: EXPERIMENTAL
Intervention: 500 mg diflunisal twice daily
Number of subjects: 52

Group type: COMPARATOR
Intervention: 500 mg mefenamic acid three times daily
Number of subjects: 52
Study: 31987558

Group type: EXPERIMENTAL
Intervention: MAX (maximal hopping group)
Number of subjects: 56

Group type: COMPARATOR
Intervention: NAT (natural hopping group)
Number of subjects: 56

Group type: COMPARATOR
Intervention: No stretch, 30 s stretch, multiple (4×) 30 s stretch, and dynamic stretch (treatment conditions)
Number of subjects: 56
Study: 31429023

Group type: EXPERIMENTAL
Intervention: HTX-011
Number of subjects: 418
Study: 28246237

Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 3876

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3876
Study: 25869658

Group type: EXPERIMENTAL
Intervention: Intradialysis yoga
Number of subjects: 31

Group type: COMPARATOR
Intervention: Educational program
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Intradialysis yoga and Educational program
Number of subjects: 31
Study: 24279841

Group type: EXPERIMENTAL
Intervention: GET.ON‐Mood Enhancer‐WL (web-based guided self-help intervention) in addition to treatment as usual (TAU)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) alone
Number of subjects: 200
Study: 21431880

Group type: EXPERIMENTAL
Intervention: Endurance-trained (Tr)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Untrained (UTr)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 19615830

Group type: EXPERIMENTAL
Intervention: Abstinence Contingent (AC) group, n=35
Number of subjects: 68

Group type: COMPARATOR
Intervention: Yoked Control (YC) group, n=33
Number of subjects: 68
Study: 17580512

Group type: COMPARATOR
Intervention: Traditional fixed appliances
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Orthotropic treatment (growth guidance)
Number of subjects: 12
Study: 15611487

Group type: EXPERIMENTAL
Intervention: True acupuncture (23 sessions over 26 weeks)
Number of subjects: 570

Group type: COMPARATOR
Intervention: Sham acupuncture (23 sessions over 26 weeks)
Number of subjects: 570

Group type: COMPARATOR
Intervention: Education (6 two-hour sessions over 12 weeks)
Number of subjects: 570
Study: 15767953

Group type: EXPERIMENTAL
Intervention: Morphine aerosols (4 mls of morphine sulphate nebulised 4 hourly)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Normal saline aerosols (4 mls of normal saline nebulised 4 hourly)
Number of subjects: 12
Study: 10024851

Group type: EXPERIMENTAL
Intervention: 4-choice-compatible condition (females)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 4-choice-compatible condition (males)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Overall reaction time advantage
Number of subjects: 24
Study: 7736406

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU)/interferon alfa-2A (IFN-alpha)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 5-fluorouracil (5-FU)/leucovorin
Number of subjects: 30

Group type: COMPARATOR
Intervention: 5-fluorouracil (5-FU) alone
Number of subjects: 30
Study: 2293252

Group type: EXPERIMENTAL
Intervention: Clomipramine 75mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 7363639

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 267

Group type: COMPARATOR
Intervention: Amoxycillin
Number of subjects: 267
Study: 30581100

Group type: EXPERIMENTAL
Intervention: IMT + CT
Number of subjects: 24
Study: 28744114

Group type: EXPERIMENTAL
Intervention: Power Training (PT)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Power Training (PT) and Resistance Training (RT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control Session (CS)
Number of subjects: 21
Study: 27208378

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (group and individual counseling)
Number of subjects: 319

Group type: COMPARATOR
Intervention: Diabetes support and education (control group)
Number of subjects: 319
Study: 23148779

Group type: EXPERIMENTAL
Intervention: Nonceramic hydroxyapatite (ncHA)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Intraoral autogenous bone graft
Number of subjects: 11
Study: 22768848

Group type: EXPERIMENTAL
Intervention: Discharge planning therapies primarily within the home environment
Number of subjects: 400

Group type: COMPARATOR
Intervention: In-hospital consultation
Number of subjects: 400
Study: 19361594

Group type: EXPERIMENTAL
Intervention: Taxus stent implantation
Number of subjects: 74

Group type: COMPARATOR
Intervention: Cypher stent implantation
Number of subjects: 74
Study: 17586374

Group type: EXPERIMENTAL
Intervention: Superior-hinged LASIK flap
Number of subjects: 33

Group type: COMPARATOR
Intervention: Temporal-hinged LASIK flap
Number of subjects: 33
Study: 16342002

Group type: EXPERIMENTAL
Intervention: N,N-dimethyltryptamine (DMT)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: (S)-ketamine
Number of subjects: 15
Study: 11932129

Group type: EXPERIMENTAL
Intervention: Kidz with Leukemia: A Space Adventure CD-ROM
Number of subjects: 0

Group type: COMPARATOR
Intervention: You and Leukemia book
Number of subjects: 0
Study: 9819786

Group type: EXPERIMENTAL
Intervention: moexipril 7.5 mg, uptitrated to 15 mg or 15 mg/HCTZ 25 mg if necessary
Number of subjects: 116

Group type: COMPARATOR
Intervention: atenolol 25 mg, uptitrated to 50 mg or 50 mg/HCTZ 25 mg if necessary
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: moexipril
Number of subjects: 116

Group type: COMPARATOR
Intervention: atenolol
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: moexipril and atenolol
Number of subjects: 116
Study: 7659476

Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccines
Number of subjects: 2200

Group type: COMPARATOR
Intervention: Whole-cell vaccine (WCL)
Number of subjects: 2200
Study: 31881390

Group type: EXPERIMENTAL
Intervention: Patient navigation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 29097974

Group type: EXPERIMENTAL
Intervention: Information processing strategy training (PRPP System of Intervention and 4QM), 50 minutes per session, twice a week for 6 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Traditional intervention, twice a week for 6 weeks
Number of subjects: 20
Study: 27234609

Group type: EXPERIMENTAL
Intervention: Stand-alone cage
Number of subjects: 58

Group type: COMPARATOR
Intervention: Bone autograft and plate implants
Number of subjects: 58
Study: 24330156

Group type: EXPERIMENTAL
Intervention: NF3 (two-herb traditional Chinese medicine)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: NF3
Number of subjects: 16
Study: 22374985

Group type: EXPERIMENTAL
Intervention: 3% saline nebulization
Number of subjects: 31

Group type: COMPARATOR
Intervention: 7% saline nebulization
Number of subjects: 31
Study: 19226381

Group type: EXPERIMENTAL
Intervention: Entecavir 0.5 mg/day for 52 weeks
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Entecavir 1.0 mg/day for 52 weeks
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Entecavir 1.0 mg/day for additional 68-92 weeks
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Entecavir treatment with annual liver biopsies
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Entecavir treatment
Number of subjects: 19
Study: 16451148

Group type: EXPERIMENTAL
Intervention: Esmolol (n=25)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Remifentanil (n=26)
Number of subjects: 51
Study: 15197121

Group type: EXPERIMENTAL
Intervention: Lateral recumbent head-down position
Number of subjects: 450

Group type: COMPARATOR
Intervention: Lateral recumbent horizontal position
Number of subjects: 450

Group type: COMPARATOR
Intervention: Sitting position
Number of subjects: 450
Study: 11726010

Group type: EXPERIMENTAL
Intervention: Treatment with diuretics or beta-blockers (Group 1)
Number of subjects: 512

Group type: COMPARATOR
Intervention: Treatment with calcium channel blockers or angiotensin-converting enzyme inhibitors (Group 2)
Number of subjects: 512
Study: 9164833

Group type: EXPERIMENTAL
Intervention: SCT+Ca (100 IU/day I.M. of SCT plus 1200 mg of elemental Ca for 10 days each month)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ca (1200 mg of elemental Ca for 10 days each month)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 7964696

Group type: EXPERIMENTAL
Intervention: Patients with progressive supranuclear palsy (PSP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients with Parkinson's disease (PD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment with L-dopa in Parkinson's disease
Number of subjects: 0
Study: 3609189

Group type: EXPERIMENTAL
Intervention: Inhaled terbutaline (2 X 4 mg)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Subcutaneous adrenaline (2 X 0.5 mg)
Number of subjects: 46
Study: 29571007

Group type: EXPERIMENTAL
Intervention: Time-restricted feeding (TRF)
Number of subjects: 40
Study: 27207526

Group type: EXPERIMENTAL
Intervention: Diazoxide
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 25722360

Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT) for 6 weeks, weekly sessions.
Number of subjects: 0
Study: 23916629

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Intervention (CBI)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Supportive Intervention (SI)
Number of subjects: 25
Study: 20516379

Group type: EXPERIMENTAL
Intervention: cilostazol (100 to 200 mg/d)
Number of subjects: 329

Group type: COMPARATOR
Intervention: aspirin (81 to 100 mg/d)
Number of subjects: 329
Study: 19264451

Group type: EXPERIMENTAL
Intervention: Levetiracetam XR 1000mg o.d.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Levetiracetam IR 500mg b.i.d.
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Levetiracetam XR with food (1000mg single dose)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Levetiracetam XR (1000, 2000, and 3000mg)
Number of subjects: 24
Study: 15723428

Group type: EXPERIMENTAL
Intervention: Generic formulation of nizatidine 300 mg capsules
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Innovator formulation of nizatidine 300 mg capsules
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison of both formulations
Number of subjects: 20